MOG peptide (79-96) rat

MOG peptide (79-96) rat is a myelin oligodendrocyte glycoprotein (MOG) with encephalitogenic effects[1].

Product Specifications

CAS Number

[356038-17-0]

UNSPSC

12352209

Target

Others

Type

Peptides

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/mog-peptide-79-96-rat.html

Solubility

10 mM in DMSO

Smiles

NCCCC[C@H](NC(CN)=O)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CCC(O)=O)C(NCC(NCC(N[C@H](C(O)=O)CC1=CC=C(C=C1)O)=O)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C88H141N27O27

Molecular Weight

2009.23

References & Citations

[1]Abdul-Majid KB, et al. Screening of several H-2 congenic mouse strains identified H-2 (q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol. 2000 Nov 1;111 (1-2) :23-33.